New Data Suggest Veracyte's Afirma Molecular Testing Capabilities Can Help Advance Scientific Understanding of Thyroid Nodules and Cancer

Findings presented at ENDO 2023 also confirm analytical validity of company’s TERT promoter gene mutation testing for thyroid nodule patients

... | June 20, 2023

Related Keywords

United States ,Allan Golding ,Sina Jasmin ,Joshua Klopper ,Endocrine Society ,Washington University In St ,Veracyte Inc ,Nasdaq ,Twitter ,Company Afirma ,Afirma Genomic Sequencing Classifier ,Memorial Healthcare System ,Washington University ,Expression Atlas ,Annual Report ,Quarterly Report ,